pI: 5.6363 |
Length (AA): 733 |
MW (Da): 79234 |
Paralog Number:
1
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
368 | 711 | 4hwy (A) | 45 | 334 | 28.00 | 0 | 1 | 0.579304 | 0.28 |
415 | 733 | 5egw (A) | 131 | 384 | 31.00 | 0.000000000012 | 0.95 | 0.260598 | 0.67 |
646 | 693 | 2wbf (X) | 754 | 801 | 50.00 | 0.000000028 | 0.76 | 0.687884 | -0.59 |
666 | 713 | 2fo5 (A) | 175 | 226 | 33.00 | 0.027 | 0.42 | 0.314384 | 0.31 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Hehl AB Fritz HM Sibley/Greg |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_130494)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_I000540 | preprocathepsin c precursor, putative |
Babesia bovis | BBOV_II000170 | cathepsin C precursor, putative |
Caenorhabditis elegans | CELE_F36D3.9 | Protein CPR-2 |
Cryptosporidium hominis | Chro.40239 | preprocathepsin c precursor |
Cryptosporidium parvum | cgd4_2110 | preprocathepsin c precursor, putative |
Dictyostelium discoideum | DDB_G0292462 | hypothetical protein |
Giardia lamblia | GL50803_14566 | Dipeptidyl-peptidase I precursor |
Homo sapiens | ENSG00000109861 | cathepsin C |
Mus musculus | ENSMUSG00000030560 | cathepsin C |
Neospora caninum | NCLIV_041870 | hypothetical protein |
Plasmodium berghei | PBANKA_1460700 | dipeptidyl aminopeptidase 2 |
Plasmodium berghei | PBANKA_0931300 | dipeptidyl aminopeptidase 1, putative |
Plasmodium falciparum | PF3D7_1116700 | dipeptidyl aminopeptidase 1 |
Plasmodium falciparum | PF3D7_1247800 | dipeptidyl aminopeptidase 2 |
Plasmodium knowlesi | PKNH_1467500 | dipeptidyl aminopeptidase 2, putative |
Plasmodium knowlesi | PKNH_0914400 | dipeptidyl aminopeptidase 1, putative |
Plasmodium vivax | PVX_091465 | dipeptidyl aminopeptidase 1, putative |
Plasmodium vivax | PVX_101280 | dipeptidyl aminopeptidase 2, putative |
Plasmodium yoelii | PY02150 | Homo sapiens P3ECSL-related |
Plasmodium yoelii | PY05365 | cathepsin c precursor |
Schistosoma japonicum | Sjp_0207730 | Cathepsin C precursor, putative |
Schistosoma japonicum | Sjp_0207740 | ko:K01275 cathepsin C [EC3.4.14.1], putative |
Schistosoma mansoni | Smp_019030 | dipeptidyl-peptidase I (C01 family) |
Schmidtea mediterranea | mk4.002926.00 | Dipeptidyl peptidase 1 |
Schmidtea mediterranea | mk4.002926.03 | Dipeptidyl peptidase 1 |
Toxoplasma gondii | TGME49_289620 | cathepsin CPC1 |
Toxoplasma gondii | TGME49_267490 | preprocathepsin c precursor, putative |
Theileria parva | TP02_0883 | cathepsin C, putative |
Theileria parva | TP03_0357 | cathepsin C, putative |
Trichomonas vaginalis | TVAG_159150 | Clan CA, family C1, cathepsin B-like cysteine peptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0931300 | Plasmodium berghei | Essential | plasmo |
PBANKA_1460700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_289620 this record | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_267490 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | cathepsin C | Compounds | References |
Mus musculus | cathepsin C | Compounds | References |
Infectious bronchitis virus | 3C-like protease | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Cathepsin L | 334 aa | 28.4% | 306 aa | Compounds | References |
Bos taurus | Cathepsin B | 335 aa | 28.7% | 296 aa | Compounds | References |
Rattus norvegicus | Cathepsin S | 330 aa | 25.9% | 301 aa | Compounds | References |
Rattus norvegicus | Cathepsin L | 334 aa | 28.1% | 295 aa | Compounds | References |
Capra hircus | Cathepsin H | 335 aa | 28.1% | 288 aa | Compounds | References |
Trypanosoma brucei | cysteine peptidase C (CPC) | 340 aa | 27.6% | 290 aa | Compounds | References |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 345 aa | 27.4% | 285 aa | Compounds | References |
Rattus norvegicus | Cathepsin B | 339 aa | 29.4% | 310 aa | Compounds | References |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 340 aa | 27.6% | 286 aa | Compounds | References |
Rattus norvegicus | Cathepsin K | 329 aa | 25.8% | 287 aa | Compounds | References |
Oryctolagus cuniculus | Cathepsin K | 329 aa | 23.6% | 351 aa | Compounds | References |
Capra hircus | Cathepsin B | 335 aa | 28.6% | 304 aa | Compounds | References |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 340 aa | 25.8% | 291 aa | Compounds | References |
Canis familiaris | Cathepsin K | 330 aa | 23.4% | 384 aa | Compounds | References |
21 literature references were collected for this gene.